Poslední aktualizace :
19/11/2024
Bendrasis anestetikas   Thiopental sodium  
Įpurškimas
Tirpalų stabilumas Mišinių stabilumas Stabilumą lemiantys veiksniai Suderinamumas Leidimo būdai Bibliografija pdf
   Cheminė sandara  

Prekinis pavadinimas   Prekinis pavadinimas     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Anapental Egiptas
Anental Kolumbija, Venesuela
Epental Saudo Arabija
Exipental Iranas
Farmotal Italija
Gabapentax Kolumbija
Hipnopento Argentina
Nesdonal Olandija
Pantul Ekvadoras, Peru
Pensodital Meksikas
Pental Turkija
Pentarim Meksikas
Pentax Venesuela
Pentocur Islandija, Norvegija
Pentotex Malaizija
Pentothal Australija, Belgija, Danija, Graikija, Italija, Kanada, Liuksemburgas, Meksikas, Suomija, Švedija, Šveicarija
Sodipental Kolumbija, Meksikas
Thiojex Čilė
Thiomek Peru
Thiopental Airija, Austrija, Didžioji Britanija, Egiptas, Graikija, Iranas, Lenkija, Malaizija, Marokas, Prancūzija, Rumunija, Saudo Arabija, Tunisas, Vengrija, Vokietija
Thiopentax Ekvadoras, Venesuela
Tiobarbital Ispanija, Kolumbija
Trapanal Vokietija
Zedisol Meksikas
Bibliografija   Įpurškimas   Bibliografija : Thiopental sodium  
tipas leidinys
59 Žurnalas Trissel LA, Gilbert DL, Martinez JF, Kim MC.
Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 2192-2196.
125 Žurnalas Chernin EL, Stewart JT, Smiler B.
Stability of thiopental sodium and propofol in polypropylene syringes at 23 and 4°C.
Am J Health-Syst Pharm 1996 ; 53: 1576-1579.
126 Žurnalas Prankerd RJ, Jones RD.
Physicochemical compatibility of propofol with thiopental sodium.
Am J Health-Syst Pharm 1996 ; 53: 2606-2610.
299 Žurnalas Trissel LA, Martinez JF, Gilbert DL.
Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1735-1741.
314 Žurnalas Chiu MF, Schwartz ML.
Visual compatibility of injectable drugs used in the intensive care unit.
Am J Health-Syst Pharm 1997 ; 54: 64-65.
319 Žurnalas Hadzija BW, Lubarsky DA.
Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia.
Am J Health-Syst Pharm 1995 ; 52: 997-999.
350 Žurnalas Martens HJ, De Goede PN, Van Loenen AC.
Sorption of various drugs in polyvinyl chloride, glass, and polyethylene-lined infusion containers.
Am J Hosp Pharm 1990 ; 47: 369-373.
527 Žurnalas Das Gupta V, Neal Gardner S, Jolowsky CM, Newcomer DR, Stewart KR.
Chemical stability of thiopental sodium injection in disposable plastic syringes.
J Clin Pharm Ther 1987 ; 12: 339-342.
642 Žurnalas Baumgartner TG, Knudsen AK, Dunn AJ, Kilroy RA.
Norepinephrine stability in saline solutions.
Hosp Pharm 1988 ; 23: 44,49, 59.
755 Laboratorija Pancuronium (Pavulon®) - Résumé des caractéristiques du produit
MSD France 2016
871 Žurnalas Haws JL, Herman N, Clark Y, Bjoraker R, Jones D.
The chemical stability and sterility of sodium thiopental after preparation.
Anesth Analg 1998 ; 86: 208-213.
919 Žurnalas Lazar ER, Jolly DT, Tam YK, Hrazdil J, Tawfik SR, Clanachan AS.
Propofol and thiopental in a 1:1 volume mixture is chemically stable.
Anesth Analg 1998 ; 86: 422-426.
1173 Žurnalas Kowaluk EA, Roberts MS, Blackburn HD, Polack AE.
Interactions between drugs and polyvinyl chloride infusion bags.
Am J Hosp Pharm 1981 ; 38: 1308-1314.
1713 Žurnalas Trissel LA, Saenz CA.
Compatibility screening of bivalirudin during simulated Y-site administration with other drugs.
Int J Pharm Compound 2002 ; 6: 311-315.
1721 Žurnalas Trissel LA, Williams KY, Baker MB.
Compatibility screening of Hextend during simulated Y-site administration with other drugs.
Int J Pharm Compound 2001 ; 5: 69-72.
1803 Žurnalas Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB.
Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2003 ; 60: 80-85.
2073 Žurnalas Taniguchi T, Yamamoto K, Kobayashi T.
Precipitate formed by thiopentone and vecuronium causes pulmonary embolism.
Can J Anesth 1998 ; 45: 347-351.
2079 Žurnalas Morton WD, Lerman J.
The effect of pancuronium on the solubility of aqueous thiopentone.
Can J Anesth 1987 ; 34: 87-89.
2090 Žurnalas Pere H, Chasse V, Forest JM, Hildgen P.
Compatibility of injectable pantoprazole in Y-site administration.
Pharmactuel 2004 ; 37: 193-196.
2105 Žurnalas Valverde molina F, Hernandez Hernandez G, Munoz Castillo M, Novales Duran J, Gallego Fernandez C.
Estabilidad de una mezcla de etomidato y pentotal para administracion intravenosa en bolo.
Farm Hosp 1999 ; 23: 357-360.
2146 Žurnalas Trissel LA, Xu QA, Baker M.
Drug compatibility with new polyolefin infusion solution containers.
Am J Health-Syst Pharm 2006 ; 63: 2379-2382.
2231 Žurnalas de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S.
Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection.
J Antimicrob Chemother 2008 ; 61, 2: 382-388.
3134 Žurnalas Perez Jua En, Maqueda Palau M, Arévalo Rubert Mt, Ribas Nicolau B, Amoros Cerdà SM.
Compatibilidad visual y física de la furosemida en mezclas intravenosas para perfusión continua.
Enferm Intensiva 2010 ; 21: 96-103.
3212 Žurnalas Ribas Nicolau, B.; P?rez Juan, E.; Amor?s Cerd?, S.M.; Ar?valo Rubert, M.J.; Maqueda Palau, M.
Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos.
Enferm Intensiva 2011 ;22:78-82.
3372 Žurnalas Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S.
Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine.
Rev Bras Anestesiol 2013 ; 63, 1: 163-166.
3373 Žurnalas Khan S, Stannard N, Greijn J.
Precipitation of thiopental with muscle relaxants: a potential hazard.
J R Soc Med Sh Rep 2011 ; 2: 58.
3377 Žurnalas Huddy NC, Durcan JJ.
Precipitation betwen meptazinol and thiopentone.
Anaesthesia 1983 ; 38: 601-602.
3408 Žurnalas Tollec S, Touzin K, Pelletier E, Forest J.M.
Evaluation visuelle de la compatibilité physique de la naloxone avec d’autres médicaments intraveineux usuels.
Pharmactuel 2013 ; 46, 1 : 16-21.
3464 Žurnalas Monica Maqueda-Palau, Eva Pérez-Juan, Maria Josep Arévalo-Rubert, Sylvia Monica Amoros-Cerda, Bàrbara Ribas-Nicolau.
Compatibilidad física de la amiodarona en perfusión continua
Enferm Clin 2011 21:25-29.
3466 Žurnalas B. Ribas Nicolau, E. P?rez Juan, S.M. Amor?s Cerd?, M.J. Ar?valo Rubert, M. Maqueda Palau.
Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos
Enferm Intensiva 2011 ;22:78-82.
3501 Laboratorija Ketamine hydrochloride (Ketalar®) - Summary of Product Characteristics
Pfizer 2011
3503 Laboratorija Fentanyl - Summary of product Characteristics
Hameln Pharmaceuticals 2012
3525 Laboratorija Pethidine hydrochloride - Summary of product Characteristics
AMCO Amdipharm Mercury 2012
3526 Laboratorija Clindamycin (Dalacin®) - Summary of Product Characteristics
Pharmacia 2010
3531 Laboratorija Morphine sulphate 10 mg/mL injection BP – Summary of Product Characteristics
Wockhardt 2014
3549 Laboratorija Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3564 Laboratorija Rocuronium B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3599 Laboratorija Glycopyrrolate Injection U.S.P. - Summary of Product Characteristics
Amco Amdipharm Mercry 2013
3600 Laboratorija Hydroxyzine (Atarax®) - Résumé des caractéristiques du produit
UCB Pharma SA 2009
3601 Laboratorija Cisatracurium Actavis - Résumé des Caractéristiques du Produit
Actavis 2012
3607 Laboratorija Esmolol hydrochloride for injection - Summary of Product Characteristics
AOP Orphan Pharmaceuticals AG 2013
3612 Laboratorija Doxapram (Dopram) - Summary of Product Characteristics
Amdipharm Mercury Company 2012
3614 Laboratorija Nicardipine Injection - Summary of Product Characteristics
American Regent Inc 2013
3629 Laboratorija Atracurium (Atracurium solution for injection/infusion®) - Summary of Product Characteristics
Actavis UK 2014
3630 Laboratorija Vecuronium (Norcuron®) - Summary of Product Characteristics
Merck Sharp Dohme 2012
3631 Laboratorija Suxamethonium (Suxamethonium Aguettant®) - Résumé des caractéristiques du produit
Aguettant 2016
3674 Laboratorija Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
3675 Laboratorija Thiopental sodium - Summary of Product Characteristics
Archimedes Pharma UK Ltd 2015
3676 Laboratorija Atracurium bésilate (Atracurium Hospira®) - Résumé des caractéristiques du produit
Hospira 2014
3767 Žurnalas Legris M.E, Lavoie A, Forrest J.M, Hildgen P.
Compatibilité par évaluation visuelle du thiopental injectable lors de son administration en Y avec des médicaments usuels.
Pharmactuel 2014 ; 47, 3 : 167-172.
3823 Žurnalas Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R.
Compatibilité physique de médicaments administrés dans l’unité de soins intensifs
Pharmactuel 2015 ; 48, 3 : 146-152.
3932 Laboratorija Hydroxocobalamine (Cyanokit®) - Résumé des caractéristiques du produit
Serb Laboratoire 2015
3941 Laboratorija Nicardipine - Summary of Product Characteristics
Concordia International 2017
4009 Laboratorija
Droperidol - Résumé des Caractéristiques du Produit
Panpharma 2017
4428 Žurnalas Rashed S.M, Sweatman T.W, Thoma L, Hovinga C.A, Phelps S.J.
Chemical Compatibility of Depacon® with Medications Frequently Administered by Intravenous Y-Site Delivery in Patients with Epilepsy or Head Trauma.
J Pediatr Pharmacol Ther 2004 ; 9, 2: 126-132.
4700 Laboratorija Esketamine 25 mg/mL solution for injection/infusion. - Summary of Product Characteristics
AS Kalceks 2022

  Mentions Légales